Forest Laboratories (FRX)
Add to Watchlists Create an AlertForest Laboratories Enterprise Value:
8.732B for May 24, 2013Forest Laboratories Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 24, 2013 | 8.732B |
| May 23, 2013 | 8.806B |
| May 22, 2013 | 8.268B |
| May 21, 2013 | 8.378B |
| May 20, 2013 | 8.394B |
| May 17, 2013 | 8.540B |
| May 16, 2013 | 8.585B |
| May 15, 2013 | 8.671B |
| May 14, 2013 | 8.583B |
| May 13, 2013 | 8.442B |
| May 10, 2013 | 8.468B |
| May 9, 2013 | 8.388B |
| May 8, 2013 | 8.319B |
| May 7, 2013 | 8.125B |
| May 6, 2013 | 8.186B |
| May 3, 2013 | 8.284B |
| May 2, 2013 | 8.159B |
| May 1, 2013 | 8.141B |
| April 30, 2013 | 8.242B |
| April 29, 2013 | 8.189B |
| April 26, 2013 | 8.141B |
| April 25, 2013 | 8.119B |
| April 24, 2013 | 8.130B |
| April 23, 2013 | 8.093B |
| April 22, 2013 | 7.904B |
| April 19, 2013 | 7.842B |
| April 18, 2013 | 7.717B |
| April 17, 2013 | 7.757B |
| April 16, 2013 | 7.781B |
| April 15, 2013 | 7.896B |
| April 12, 2013 | 8.396B |
| April 11, 2013 | 8.481B |
| April 10, 2013 | 8.418B |
| April 9, 2013 | 8.223B |
| April 8, 2013 | 8.263B |
| April 5, 2013 | 8.271B |
| April 4, 2013 | 8.308B |
| April 3, 2013 | 8.250B |
| April 2, 2013 | 8.332B |
| April 1, 2013 | 8.362B |
| March 28, 2013 | 8.410B |
| March 27, 2013 | 8.263B |
| March 26, 2013 | 8.322B |
| March 25, 2013 | 8.250B |
| March 22, 2013 | 8.340B |
| March 21, 2013 | 8.380B |
| March 20, 2013 | 8.402B |
| March 19, 2013 | 8.292B |
| March 18, 2013 | 8.295B |
| March 15, 2013 | 8.410B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
FRX Enterprise Value Benchmarks
| Companies | |
|---|---|
| Ironwood Pharmaceuticals | 1.294B |
| Catalyst Pharmaceutical Partners | 19.17M |
| Valeant Pharmaceuticals International | 33.04B |
FRX Enterprise Value Rankings
| Overall |
91st percentile 702 of 8011 |
| Sector |
90th percentile 63 of 687 in Healthcare |
| Industry |
89th percentile 7 of 69 in Drug Manufacturers - Specialty & Generic |
FRX Enterprise Value Range, Past 5 Years
| Minimum | 3.477B | Mar 9 2009 |
| Maximum | 9.969B | Aug 15 2008 |
| Average | 6.205B |
